Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling

Sarah H. Lockie, Kristy M. Heppner, Nilika Chaudhary, Joseph R. Chabenne, Donald A. Morgan, Christelle Veyrat-Durebex, Gayathri Ananthakrishnan, Françoise Rohner-Jeanrenaud, Daniel J. Drucker, Richard DiMarchi, Kamal Rahmouni, Brian J. Oldfield, Matthias H. Tschöp, Diego Perez-Tilve

Research output: Contribution to journalArticlepeer-review

197 Scopus citations

Abstract

We studied interscapular brown adipose tissue (iBAT) activity in wild-type (WT) and glucagon-like peptide 1 receptor (GLP-1R)- deficient mice after the administration of the proglucagon-derived peptides (PGDPs) glucagon-like peptide (GLP-1), glucagon (GCG), and oxyntomodulin (OXM) directly into the brain. Intra-cerebroventricular injection of PGDPs reduces body weight and increases iBAT thermogenesis. This was independent of changes in feeding and insulin responsiveness but correlated with increased activity of sympathetic fibers innervating brown adipose tissue (BAT). Despite being a GCG receptor agonist, OXM requires GLP-1R activation to induce iBAT thermogenesis. The increase in thermogenesis in WT mice correlates with increased expression of genes upregulated by adrenergic signaling and required for iBAT thermogenesis, including PGC1a and UCP-1. In spite of the increase in iBAT thermogenesis induced by GLP-1R activation in WT mice, Glp1r-/- mice exhibit a normal response to cold exposure, demonstrating that endogenous GLP-1R signaling is not essential for appropriate thermogenic response after cold exposure. Our data suggest that the increase in BAT thermogenesis may be an additional mechanism whereby pharmacological GLP-1R activation controls energy balance.

Original languageEnglish
Pages (from-to)2753-2762
Number of pages10
JournalDiabetes
Volume61
Issue number11
DOIs
StatePublished - Nov 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling'. Together they form a unique fingerprint.

Cite this